Fehrenbacher A

Title : Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors - Samochocki_2003_J.Pharmacol.Exp.Ther_305_1024

Author(s) : Samochocki M , Hoffle A , Fehrenbacher A , Jostock R , Ludwig J , Christner C , Radina M , Zerlin M , Ullmer C , Pereira EF , Lubbert H , Albuquerque EX , Maelicke A

Ref : Journal of Pharmacology & Experimental Therapeutics , 305 :1024 , 2003

Abstract :

PubMedSearch : Samochocki_2003_J.Pharmacol.Exp.Ther_305_1024

PubMedID: 12649296

Title : Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease - Maelicke_2001_Biol.Psychiatry_49_279

Author(s) : Maelicke A , Samochocki M , Jostock R , Fehrenbacher A , Ludwig J , Albuquerque EX , Zerlin M

Ref : Biological Psychiatry , 49 :279 , 2001

Abstract :

PubMedSearch : Maelicke_2001_Biol.Psychiatry_49_279

PubMedID: 11230879

Fehrenbacher A

References (2)

1. Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors - Samochocki_2003_J.Pharmacol.Exp.Ther_305_1024

2. Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease - Maelicke_2001_Biol.Psychiatry_49_279